Cargando…
Exploring the Multi-Target Performance of Mitochondriotropic Antioxidants against the Pivotal Alzheimer’s Disease Pathophysiological Hallmarks
Alzheimer disease (AD) is the most common neurodegenerative disease featuring progressive and degenerative neurological impairments resulting in memory loss and cognitive decline. The specific mechanisms underlying AD are still poorly understood, but it is suggested that a deficiency in the brain ne...
Autores principales: | Benfeito, Sofia, Fernandes, Carlos, Vilar, Santiago, Remião, Fernando, Uriarte, Eugenio, Borges, Fernanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024345/ https://www.ncbi.nlm.nih.gov/pubmed/31936622 http://dx.doi.org/10.3390/molecules25020276 |
Ejemplares similares
-
Hydroxybenzoic Acid Derivatives as Dual-Target Ligands: Mitochondriotropic Antioxidants and Cholinesterase Inhibitors
por: Oliveira, Catarina, et al.
Publicado: (2018) -
Fine-Tuning the Biological Profile of Multitarget Mitochondriotropic Antioxidants for Neurodegenerative Diseases
por: Chavarria, Daniel, et al.
Publicado: (2021) -
Engineering Mitochondriotropic Carbon Dots for Targeting Cancer Cells
por: Kaminari, Archontia, et al.
Publicado: (2021) -
Research Models to Study Ferroptosis’s Impact in Neurodegenerative Diseases
por: Costa, Inês, et al.
Publicado: (2023) -
Mitochondriotropic and Cardioprotective Effects of Triphenylphosphonium-Conjugated Derivatives of the Diterpenoid Isosteviol
por: Testai, Lara, et al.
Publicado: (2017)